CLINICAL_TRIALS
ClinicalTrials.gov record update
A Phase 2 Study of R-(-)-Gossypol (Ascenta's AT-101) in Recurrent Glioblastoma Multiforme
This page presents selected fields from the linked source record. It does not add a medical interpretation.
Record identity and dates
- Source
- ClinicalTrials.gov
- Source record ID
- NCT00540722
- Title field or adapter rule
- protocolSection.identificationModule.officialTitle
- Ingested At
- 2026-04-28T10:36:28.392234+00:00
- Published At
- 2017-07-12T00:00:00+00:00
- Record Updated At
- 2017-08-11
- Results Posted At
- 2017-07-12
- Timestamp Basis
- source retrieval time was not retained by the feed adapter
- Date limitation
- source retrieval time was not retained by the feed adapter
Fields recorded by this source
- protocolSection.conditionsModule.conditions
["Adult Giant Cell Glioblastoma", "Adult Glioblastoma", "Adult Gliosarcoma", "Recurrent Adult Brain Tumor"]- protocolSection.statusModule.lastUpdatePostDateStruct.date
"2017-08-11"- protocolSection.identificationModule.nctId
"NCT00540722"- protocolSection.identificationModule.officialTitle
"A Phase 2 Study of R-(-)-Gossypol (Ascenta\u0027s AT-101) in Recurrent Glioblastoma Multiforme"- protocolSection.statusModule.overallStatus
"COMPLETED"- protocolSection.designModule.phases
["PHASE2"]- protocolSection.statusModule.resultsFirstPostDateStruct.date
"2017-07-12"
Study condition terms
Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.
This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.